Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ · Healthcare
Cumberland Pharmaceuticals Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 44.5M | 37.9M | 39.6M | 42.0M | 35.0M | 35.8M | 32.4M | 28.8M | 40.4M | 32.5M | 900,000 | 600,000 | 800,000 | 700,000 | 51.1M | 45.9M | 43.5M |
| Gross Profit | 37.9M | 31.3M | 33.5M | 32.9M | 26.2M | 27.2M | 25.0M | 22.8M | 33.0M | 26.5M | -4.1M | -4.5M | -4.6M | -4.3M | 45.8M | 42.3M | 39.4M |
| Profitability | |||||||||||||||||
| Operating Income | -2.8M | -6.4M | -9.6M | -5.7M | -7.7M | -6.4M | -9.3M | -11.2M | -4.1M | -1.4M | 1.1M | 3.6M | -3.8M | 8.8M | 9.8M | 6.5M | 5.8M |
| EBITDA | 1.4M | -1.5M | -4.6M | -376,816 | -3.1M | -1.6M | -4.9M | -8.2M | -1.4M | 963,777 | 3.4M | 5.5M | -2.5M | 9.7M | 10.9M | 7.5M | 6.6M |
| Net Income | -2.8M | -6.5M | -6.3M | -5.6M | -3.5M | -3.3M | -3.5M | -7.0M | -8.0M | -944,683 | 731,351 | 2.4M | -2.1M | 5.8M | 5.7M | 2.5M | 3.1M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 15M | 14M | 14M | 15M | 15M | 15M | 15M | 16M | 16M | 16M | 17M | 18M | 18M | 20M | 21M | 21M | 18M |
Cumberland Pharmaceuticals Inc. Income Statement — FAQ
Cumberland Pharmaceuticals Inc. (CPIX) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPIX's income statement history?
The chart and table above show Cumberland Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.